| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cancer chemotherapy: A critical analysis of its 60 years of history
|
Galmarini, Darío
|
|
2012
|
84 |
2 |
p. 181-199
19 p.
|
artikel
|
| 2 |
Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma
|
Vagace, Jose Manuel
|
|
2012
|
84 |
2 |
p. 274-286
13 p.
|
artikel
|
| 3 |
Current issues in combined modality therapy in locally advanced head and neck cancer
|
Cmelak, Anthony J.
|
|
2012
|
84 |
2 |
p. 261-273
13 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2012
|
84 |
2 |
p. CO2-
1 p.
|
artikel
|
| 5 |
Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer
|
Farhat, Fadi S.
|
|
2012
|
84 |
2 |
p. 149-160
12 p.
|
artikel
|
| 6 |
HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients
|
Hinten, F.
|
|
2012
|
84 |
2 |
p. 161-180
20 p.
|
artikel
|
| 7 |
Management of “unfavourable” carcinoma of unknown primary site: Synthesis of recent literature
|
Amela, Eric Yaovi
|
|
2012
|
84 |
2 |
p. 213-223
11 p.
|
artikel
|
| 8 |
Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline
|
De Vos, F.Y.F.L.
|
|
2012
|
84 |
2 |
p. 252-260
9 p.
|
artikel
|
| 9 |
Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: Where are we now and where are we going?
|
Fedele, Palma
|
|
2012
|
84 |
2 |
p. 243-251
9 p.
|
artikel
|
| 10 |
The expanding options for front-line treatment in patients with newly diagnosed CML
|
Pinilla-Ibarz, Javier
|
|
2012
|
84 |
2 |
p. 287-299
13 p.
|
artikel
|
| 11 |
The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma
|
Linton, Anthony
|
|
2012
|
84 |
2 |
p. 200-212
13 p.
|
artikel
|
| 12 |
Turning promise into progress for antiangiogenic agents in epithelial ovarian cancer
|
van der Bilt, Arne R.M.
|
|
2012
|
84 |
2 |
p. 224-242
19 p.
|
artikel
|
Tijdschrift beschrijving